Cargando…
Tight Blood Pressure Control in Chronic Kidney Disease
Hypertension affects over a billion people worldwide and is the leading cause of cardiovascular disease and premature death worldwide, as well as one of the key determinants of chronic kidney disease worldwide. People with chronic kidney disease and hypertension are at very high risk of renal outcom...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144041/ https://www.ncbi.nlm.nih.gov/pubmed/35621850 http://dx.doi.org/10.3390/jcdd9050139 |
_version_ | 1784715952170991616 |
---|---|
author | Gentile, Giorgio Mckinney, Kathryn Reboldi, Gianpaolo |
author_facet | Gentile, Giorgio Mckinney, Kathryn Reboldi, Gianpaolo |
author_sort | Gentile, Giorgio |
collection | PubMed |
description | Hypertension affects over a billion people worldwide and is the leading cause of cardiovascular disease and premature death worldwide, as well as one of the key determinants of chronic kidney disease worldwide. People with chronic kidney disease and hypertension are at very high risk of renal outcomes, including progression to end-stage renal disease, and, even more importantly, cardiovascular outcomes. Hence, blood pressure control is crucial in reducing the human and socio-economic burden of renal and cardiovascular outcomes in those patients. However, current guidelines from hypertension and renal societies have issued different and sometimes conflicting recommendations, which risk confusing clinicians and potentially contributing to a less effective prevention of renal and cardiovascular outcomes. In this review, we critically appraise existing evidence and key international guidelines, and we finally formulate our own opinion that clinicians should aim for a blood pressure target lower than 130/80 in all patients with chronic kidney disease and hypertension, unless they are frail or with multiple comorbidities. We also advocate for an even more ambitious systolic blood pressure target lower than 120 mmHg in younger patients with a lower burden of comorbidities, to minimise their risk of renal and cardiovascular events during their lifetime. |
format | Online Article Text |
id | pubmed-9144041 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91440412022-05-29 Tight Blood Pressure Control in Chronic Kidney Disease Gentile, Giorgio Mckinney, Kathryn Reboldi, Gianpaolo J Cardiovasc Dev Dis Review Hypertension affects over a billion people worldwide and is the leading cause of cardiovascular disease and premature death worldwide, as well as one of the key determinants of chronic kidney disease worldwide. People with chronic kidney disease and hypertension are at very high risk of renal outcomes, including progression to end-stage renal disease, and, even more importantly, cardiovascular outcomes. Hence, blood pressure control is crucial in reducing the human and socio-economic burden of renal and cardiovascular outcomes in those patients. However, current guidelines from hypertension and renal societies have issued different and sometimes conflicting recommendations, which risk confusing clinicians and potentially contributing to a less effective prevention of renal and cardiovascular outcomes. In this review, we critically appraise existing evidence and key international guidelines, and we finally formulate our own opinion that clinicians should aim for a blood pressure target lower than 130/80 in all patients with chronic kidney disease and hypertension, unless they are frail or with multiple comorbidities. We also advocate for an even more ambitious systolic blood pressure target lower than 120 mmHg in younger patients with a lower burden of comorbidities, to minimise their risk of renal and cardiovascular events during their lifetime. MDPI 2022-04-30 /pmc/articles/PMC9144041/ /pubmed/35621850 http://dx.doi.org/10.3390/jcdd9050139 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Gentile, Giorgio Mckinney, Kathryn Reboldi, Gianpaolo Tight Blood Pressure Control in Chronic Kidney Disease |
title | Tight Blood Pressure Control in Chronic Kidney Disease |
title_full | Tight Blood Pressure Control in Chronic Kidney Disease |
title_fullStr | Tight Blood Pressure Control in Chronic Kidney Disease |
title_full_unstemmed | Tight Blood Pressure Control in Chronic Kidney Disease |
title_short | Tight Blood Pressure Control in Chronic Kidney Disease |
title_sort | tight blood pressure control in chronic kidney disease |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144041/ https://www.ncbi.nlm.nih.gov/pubmed/35621850 http://dx.doi.org/10.3390/jcdd9050139 |
work_keys_str_mv | AT gentilegiorgio tightbloodpressurecontrolinchronickidneydisease AT mckinneykathryn tightbloodpressurecontrolinchronickidneydisease AT reboldigianpaolo tightbloodpressurecontrolinchronickidneydisease |